Literature DB >> 25934928

Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease.

Jan Petrasek1, Arvin Iracheta-Vellve1, Banishree Saha1, Abhishek Satishchandran1, Karen Kodys1, Katherine A Fitzgerald1, Evelyn A Kurt-Jones1, Gyongyi Szabo2.   

Abstract

Inflammation defines the progression of ALD from reversible to advanced stages. Translocation of bacterial LPS to the liver from the gut is necessary for alcohol-induced liver inflammation. However, it is not known whether endogenous, metabolic danger signals are required for inflammation in ALD. Uric acid and ATP, 2 major proinflammatory danger signals, were evaluated in the serum of human volunteers exposed to a single dose of ethanol or in supernatants of primary human hepatocytes exposed to ethanol. In vitro studies were used to evaluate the role of uric acid and ATP in inflammatory cross-talk between hepatocytes and immune cells. The significance of signaling downstream of uric acid and ATP in the liver was evaluated in NLRP3-deficient mice fed a Lieber-DeCarli ethanol diet. Exposure of healthy human volunteers to a single dose of ethanol resulted in increased serum levels of uric acid and ATP. In vitro, we identified hepatocytes as a significant source of these endogenous inflammatory signals. Uric acid and ATP mediated a paracrine inflammatory cross-talk between damaged hepatocytes and immune cells and significantly increased the expression of LPS-inducible cytokines, IL-1β and TNF-α, by immune cells. Deficiency of NLRP3, a ligand-sensing component of the inflammasome recognizing uric acid and ATP, prevented the development of alcohol-induced liver inflammation in mice and significantly ameliorated liver damage and steatosis. Endogenous metabolic danger signals, uric acid, and ATP are involved in inflammatory cross-talk between hepatocytes and immune cells and play a crucial role in alcohol-induced liver inflammation. © Society for Leukocyte Biology.

Entities:  

Keywords:  DAMPs; NLRP3; inflammasome; liver inflammation; sterile inflammatory response

Mesh:

Substances:

Year:  2015        PMID: 25934928      PMCID: PMC4501673          DOI: 10.1189/jlb.3AB1214-590R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  25 in total

1.  Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice.

Authors:  Kele Cui; Guoxiu Yan; Congfei Xu; Yongyan Chen; Jun Wang; Rongbin Zhou; Li Bai; Zhexiong Lian; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Hepatol       Date:  2015-01-10       Impact factor: 25.083

2.  Alcohol-induced IL-1β in the brain is mediated by NLRP3/ASC inflammasome activation that amplifies neuroinflammation.

Authors:  Dora Lippai; Shashi Bala; Jan Petrasek; Timea Csak; Ivan Levin; Evelyn A Kurt-Jones; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2013-04-26       Impact factor: 4.962

Review 3.  Innate immunity in alcoholic liver disease.

Authors:  Bin Gao; Ekihiro Seki; David A Brenner; Scott Friedman; Jessica I Cohen; Laura Nagy; Gyongyi Szabo; Samir Zakhari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-01-20       Impact factor: 4.052

4.  Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.

Authors:  Sayaka Inokuchi; Hidekazu Tsukamoto; EekJoong Park; Zhang-Xu Liu; David A Brenner; Ekihiro Seki
Journal:  Alcohol Clin Exp Res       Date:  2011-04-04       Impact factor: 3.455

5.  Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure.

Authors:  Nataly Shulga; John G Pastorino
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

6.  Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.

Authors:  E V Granowitz; B D Clark; E Vannier; M V Callahan; C A Dinarello
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

7.  Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.

Authors:  E V Granowitz; E Vannier; D D Poutsiaka; C A Dinarello
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

8.  Molecular identification of a danger signal that alerts the immune system to dying cells.

Authors:  Yan Shi; James E Evans; Kenneth L Rock
Journal:  Nature       Date:  2003-09-07       Impact factor: 49.962

9.  Alcohol-induced liver injury is modulated by Nlrp3 and Nlrc4 inflammasomes in mice.

Authors:  David A DeSantis; Chih-Wei Ko; Yang Liu; Xiuli Liu; Amy G Hise; Gabriel Nunez; Colleen M Croniger
Journal:  Mediators Inflamm       Date:  2013-12-16       Impact factor: 4.711

10.  Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals.

Authors:  Shashi Bala; Miguel Marcos; Arijeet Gattu; Donna Catalano; Gyongyi Szabo
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more
  53 in total

1.  Stellate Cells Orchestrate Concanavalin A-Induced Acute Liver Damage.

Authors:  Richa Rani; Ashish Tandon; Jiang Wang; Sudhir Kumar; Chandrashekhar R Gandhi
Journal:  Am J Pathol       Date:  2017-07-13       Impact factor: 4.307

Review 2.  Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.

Authors:  Laura E Nagy; Wen-Xing Ding; Gail Cresci; Paramananda Saikia; Vijay H Shah
Journal:  Gastroenterology       Date:  2016-02-23       Impact factor: 22.682

Review 3.  Liver inflammation and fibrosis.

Authors:  Yukinori Koyama; David A Brenner
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 4.  Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Authors:  A S Martínez-Ramírez; M Díaz-Muñoz; A Butanda-Ochoa; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2016-11-29       Impact factor: 3.765

5.  Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice.

Authors:  Arvin Iracheta-Vellve; Jan Petrasek; Benedek Gyogyosi; Shashi Bala; Timea Csak; Karen Kodys; Gyongyi Szabo
Journal:  Liver Int       Date:  2017-04-27       Impact factor: 5.828

Review 6.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

7.  Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.

Authors:  Yasodha Krishnasamy; Monika Gooz; Li Li; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2019-10-15

Review 8.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

9.  Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.

Authors:  Srinivasan Dasarathy; Mack C Mitchell; Bruce Barton; Craig J McClain; Gyongyi Szabo; Laura E Nagy; Svetlana Radaeva; Arthur J McCullough
Journal:  Contemp Clin Trials       Date:  2020-07-31       Impact factor: 2.226

Review 10.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.